Entry Detail



General Information

Database ID:exR0354128
RNA Name:hsa-miR-155-5p
RNA Type:miRNA
Chromosome:chr21
Starnd:+
Coordinate:
Start Site(bp):25573983End Site(bp):25574006
External Links:hsa-miR-155-5p



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE93850
Description:Serum miRNAs in Patients with Glioblastoma Multiforme
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:22
Number of Control:8
Number of Samples:30





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
TSC22D4
chr7
100463359
100479232
-
ACOT7
chr1
6264269
6394391
-
MRFAP1
chr4
6640091
6642745
+
SH3KBP1
chrX
19533977
19887600
-
NUFIP2
chr17
29255839
29294148
-
CENPM
chr22
41938737
41947152
-
SP100
chr2
230415942
230545606
+
ARL3
chr10
102673731
102714397
-
JAK1
chr1
64833229
65067754
-
LAPTM4A
chr2
20032650
20051628
-
SOD2
chr6
159669069
159745186
-
HNRNPLL
chr2
38561969
38603586
-
LCP1
chr13
46125920
46211871
-
AICDA
chr12
8602170
8612867
-
CD52
chr1
26317958
26320523
+
MFSD9
chr2
102714630
102736888
-
NDUFA4
chr7
10931943
10940153
-
CHEK2
chr22
28687743
28742422
-
ZMYM5
chr13
19823482
19863649
-
PGLS
chr19
17511636
17521288
+
CCNB1
chr5
69167135
69178245
+
IL2RG
chrX
71107404
71112108
-
CXXC1
chr18
50282343
50288304
-
RBM38
chr20
57391396
57409333
+
CFL1
chr11
65823022
65862026
-
PPM1B
chr2
44167969
44244384
+
ZFP36
chr19
39406847
39409412
+
FTL
chr19
48965309
48966879
+
ERH
chr14
69380128
69398299
-
VPS18
chr15
40894450
40903975
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000642
chr15
80390757
80415142
+
hsa_circ_0000892
chr19
11941431
12014514
+
hsa_circ_0001046
chr2
97024782
97033111
+
hsa_circ_0000643
chr15
80412669
80415142
+
hsa_circ_0000698
chr16
47531309
47549512
+
hsa_circ_0001146
chr20
34241449
34246936
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC021078.1
chr5
149494314
149504670
-
AC090198.1
chr8
124488510
124491643
+
AC245033.4
chr15
82533175
82540008
-
AL022311.1
chr22
37876148
37895563
+
ELOA-AS1
chr1
23706901
23778296
-
GABPB1-AS1
chr15
50354959
50372202
+
LINC00240
chr6
26956932
27059749
+
LINC01772
chr1
16460948
16468481
+
MALAT1
chr11
65497688
65506516
+
MIR155HG
chr21
25561909
25575168
+
MIR17HG
chr13
91347820
91354579
+
NORAD
chr20
36045618
36051018
-
OIP5-AS1
chr15
41283990
41309737
+
SNHG5
chr6
85650491
85678932
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE93850
Sample Source:Blood
Source Fraction:Serum
Platform:GPL22948
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:1032
Sample treatment protocol:NA
RNA Extract protocol:Serum total RNA was isolated from serum samples using the Plasma/Serum Circulating and Exosomal RNA Purification Mini Kit (Slurry Format) (Norgen Biotek Corporation, Thorold, Ontario, Canada)
RNA library preparation protocol:0.3ug of total RNA of intrahepatic cholangiocarcinoma/normal intrahepatic bile duct tissue was employed with 100 nmol/L of pCp-DY547 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 ul at 16°C overnight.



Reference

PMID:28931080
Title:Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma
Author:Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY,Wu SX
Journal:PLoS One. 2017 Sep 20;12(9):e0184969.
Description:we investigated whether 3 of the 19 miRNAs in serum could be used as prognostic biomarkers for patients with GBM.